Journal of Antimicrobial Chemotherapy (2001) 47, 693-696
© 2001 The British Society for Antimicrobial Chemotherapy
Brief report |
Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia
a Department of Microbiology, Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow G3 8SJ; b University Department of Bacteriology, Glasgow Royal Infirmary, North Glasgow University/NHS Trust; c Infection Research Group, Glasgow Dental School; d Department of Haematology, Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow, UK
This study investigated the antibiotic susceptibilities of 67 isolates of viridans streptococci from 61 cases of bacteraemia in immunocompromised paediatric patients with malignancy. The majority of patients (87%) had received prior courses of empirical antibiotic therapy, which consisted of ceftazidime plus amikacin during period 1 and piperacillin/tazobactam plus amikacin during period 2. Susceptibility to vancomycin and quinupristin/dalfopristin was 100%. Susceptibility to ß-lactam antibiotics varied. For period 1, the geometric mean MICs of all ß-lactams tested against blood culture isolates (n = 31) exceeded those against isolates (n = 36) collected from blood after the change in empirical therapy (by 3.3-fold for ceftazidime, 2.8-fold for piperacillin/tazobactam and 1.6-fold for penicillin). The selection of a ß-lactam antibiotic for empirical therapy must be made with care, as repeated courses of certain agents may be more likely to select for viridans streptococci with diminished susceptibility.
* Corresponding author. Tel: +44-141-201-0416; Fax: +44-141-201-0834; E-mail: helenkennedy{at}tinyworld.co.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. F. J. Brown, R. Hope, D. M. Livermore, G. Brick, K. Broughton, R. C. George, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06 J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii75 - ii85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Athanassopoulos, A. Pefanis, V. Sakka, D. Iliopoulos, D. Perrea, and H. Giamarellou Linezolid in Prophylaxis against Experimental Aortic Valve Endocarditis Due to Streptococcus oralis or Enterococcus faecalis Antimicrob. Agents Chemother., February 1, 2006; 50(2): 654 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cerda Zolezzi, L. M. Laplana, C. R. Calvo, P. G. Cepero, M. C. Erazo, and R. Gomez-Lus Molecular Basis of Resistance to Macrolides and Other Antibiotics in Commensal Viridans Group Streptococci and Gemella spp. and Transfer of Resistance Genes to Streptococcus pneumoniae Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3462 - 3467. [Abstract] [Full Text] [PDF]
|
|